The FTC says insulin prices started increasing in 2012, coinciding with PBMs creating “exclusionary” drug formularies.
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback